Pemafibrate therapy for non-alcoholic fatty liver disease is more effective in lean patients than obese patients - Shinozaki, Satoshi; Tahara, Toshiyuki; Miura, Kouichi; Kawarai Lefor, Alan; Yamamoto, Hironori (Clinical and Experimental Hepatology, 2022)